About Contact Us Careers

Bioresorbable Collagen Implant Market Size and Forecast, by Type (Dermal Fillers, Orthopedic Implants), End User (Hospitals, Surgical Centers, Dermatology Clinics) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 5317
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450

Bioresorbable Collagen Implant Market Outlook:

Bioresorbable Collagen Implant Market size was over USD 1.38 billion in 2025 and is anticipated to cross USD 3.03 billion by 2035, witnessing more than 8.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of bioresorbable collagen implant is assessed at USD 1.48 billion.

Bioresorbable Collagen Implant Market size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Bioresorbable collagen implants are often used in aesthetic procedures such as facial fillers and lip augmentation. The growing demand for non-surgical cosmetic treatments could drive market growth. Collagen implants can be used in orthopedic surgeries, such as tendon and ligament repair. As the aging population increases and the incidence of sports-related injuries rises, the demand for these implants may also grow.

Bioresorbable collagen implants are medical devices used in various fields of medicine, including plastic surgery, orthopedics, and wound care. These implants are made from collagen, a protein found in connective tissues, and they are designed to gradually degrade and be absorbed by the body over time. This feature makes them useful for tissue repair and regeneration. Increasing awareness among both patients and healthcare providers about the benefits of bioresorbable collagen implants can contribute to market expansion. The bioresorbable collagen implant market refers to a specialized segment within the medical and healthcare industry that focuses on the development, manufacturing, and distribution of medical devices made from collagen-based materials. These implants are designed to be inserted into the human body to serve various therapeutic and cosmetic purposes, and they possess the unique characteristic of being biodegradable or bioresorbable.

Key Bioresorbable Collagen Implant Market Insights Summary:

  • Regional Highlights:

    • By 2035, Asia Pacific is anticipated to capture a 37% revenue share in the bioresorbable collagen implant market, underpinned by the region’s expanding volume of orthopedic procedures and preference for minimally invasive techniques.
    • During 2026–2035, North America is projected to remain the second-largest regional market by 2035, supported by strong adoption of advanced medical technologies.

  • Segment Insights:

    • Across 2026–2035, the orthopedic implants segment in the bioresorbable collagen implant market is expected to represent a 61% share by 2035, spurred by the growing preference for minimally invasive orthopedic procedures.
    • By 2035, the hospitals segment is set to command a significant share over 2026–2035, fueled by rising surgical volumes and rapid technological advancements.

  • Key Growth Trends:

    • Rising Demand for Non Surgical Aesthetic Procedures
    • Technological Advancements in Collagen Implants

  • Major Challenges:

    • Regulatory Compliance and Approval
    • Product Development Costs are High

  • Key Players: Allergan, Inc., Zimmer Biomet Holdings, Inc., Galderma S.A., CollPlant Holdings Ltd., Collagen Matrix, Inc., Merz Pharma GmbH & Co. KGaA.

Global Bioresorbable Collagen Implant Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 1.38 billion
    • 2026 Market Size: USD 1.48 billion
    • Projected Market Size: USD 3.03 billion by 2035
    • Growth Forecasts: 8.2%

  • Key Regional Dynamics:

    • Largest Region: Asia Pacific (37% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, Japan, Germany, South Korea
    • Emerging Countries: India, Brazil, Singapore, Mexico, United Arab Emirates

    • Last updated on : 25 November, 2025

Growth Drivers

  • Rising Demand for Non-Surgical Aesthetic Procedures: Increasing consumer preference for minimally invasive and non-surgical cosmetic enhancements, such as facial fillers and lip augmentation, is driving the demand for collagen-based implants. Patients seek treatments that offer natural-looking results with reduced downtime, contributing to bioresorbable collagen implant market growth. According to a report, global dermal filler sales, which include collagen-based products, are projected to reach USD 13 billion by 2027.
  • Technological Advancements in Collagen Implants: Continuous innovation in collagen implant materials and manufacturing processes has led to the development of more effective and longer-lasting products. These advancements enhance overall performance and patient satisfaction, further propelling market expansion. Ongoing advancements in collagen-based implant materials are driving the market growth.
  • Orthopedic Applications and Aging Population: Collagen implants are utilized in orthopedic surgeries, particularly for tendon and ligament repair. As the global population ages, the prevalence of orthopedic conditions and sports-related injuries is increasing. This demographic shift is a significant growth driver for collagen implants in orthopedics.
  • Rising Demand for Tissue Engineering and Regenerative Medicine: Tissue engineering and regenerative medicine are rapidly evolving fields that focus on restoring or regenerating damaged or lost tissues and organs in the body. Bioresorbable collagen implants play a pivotal role in these applications. Bioresorbable collagen implants act as scaffolds in tissue engineering. When implanted in the body, they provide a structure for new cells to adhere to and grow, facilitating the regeneration of damaged tissues. For instance, in orthopedics, collagen implants can be used to repair damaged tendons or ligaments.
  • Growing Popularity of Cosmetic and Aesthetic Procedures: The cosmetic and aesthetic industry is experiencing significant growth globally, and bioresorbable collagen implants are increasingly adopted for non-surgical aesthetic enhancements. Collagen-based dermal fillers are commonly used for facial rejuvenation. They can fill in wrinkles, fine lines, and volume loss, providing a youthful appearance. Patients prefer these minimally invasive treatments due to their convenience and shorter recovery periods. Lip augmentation is a popular aesthetic procedure that often utilizes collagen implants.

Challenges

  1. Regulatory Compliance and Approval: The stringent regulatory requirements for medical devices, including collagen implants, can pose challenges for manufacturers. Meeting these standards, obtaining approvals, and navigating regulatory changes can be time-consuming and costly. The development, manufacturing, and distribution of bioresorbable collagen implants are subject to rigorous regulatory oversight in most countries. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe set stringent standards to ensure the safety, efficacy, and quality of medical devices, including collagen implants.
  2. Product Development Costs are High
  3. Competition in the Market

Bioresorbable Collagen Implant Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

8.2%

Base Year Market Size (2025)

USD 1.38 billion

Forecast Year Market Size (2035)

USD 3.03 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Bioresorbable Collagen Implant Market Segmentation:

Type Segment Analysis

The orthopedic implants segment is estimated to hold 61% share of the global bioresorbable collagen implant market by 2035. Bioresorbable collagen implants offer a minimally invasive approach for orthopedic procedures. Patients are more inclined toward procedures with quicker recovery, making collagen implants an attractive option. Minimally invasive surgeries are associated with shorter hospital stays and reduced recovery times, benefiting patients. Aging populations, advancements in implant technology, and a preference for minimally invasive procedures are driving demand for these products. Additionally, the alignment of collagen implants with regenerative medicine principles and their biocompatibility contribute to their increasing adoption in orthopedic applications.

End Users Segment Analysis

Bioresorbable collagen implant market from the hospitals segment is expected to garner a significant share in the year 2035. Hospitals are early adopters of innovative medical technologies, including bioresorbable collagen implants. Technological advancements in these implants improve patient outcomes, making hospitals more inclined to integrate them into their procedures. The global medical device sales are projected to reach USD 612 billion by the year 2027, driven by technological innovations. The hospitals segment is experiencing robust growth due to a combination of factors, including the increasing number of surgical procedures, technological advancements, and the growing demand for orthopedic, wound care, and aesthetic treatments. Hospitals, as key players in healthcare delivery, are actively adopting bioresorbable collagen implants to enhance patient outcomes and meet evolving medical needs.

Our in-depth analysis of the global market includes the following segments:

           Type

  • Dermal Fillers
  • Orthopedic Implants

 

   

           End User
  • Hospitals
  • Surgical Centers
  • Dermatology Clinics
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Bioresorbable Collagen Implant Market - Regional Analysis

APAC Market Insights

Asia Pacific industry is predicted to hold largest revenue share of 37% by 2035, Orthopedic surgeries often involve the use of bioresorbable collagen implants for tendon and ligament repair. The region's high incidence of trauma cases contributes to the growth of this segment. Orthopedic procedures account for a significant portion of surgical operations in the Asia-Pacific region, driven by trauma cases and sports injuries. The Asia Pacific region is experiencing robust growth in the market due to factors such as an aging population, increasing healthcare expenditure, a high volume of orthopedic procedures, and patient preferences for minimally invasive techniques and aesthetic enhancements. The alignment of collagen implants with these trends and the region's focus on safety and regulatory compliance further support market expansion.

North American Market Insights

The bioresorbable collagen implant market in the North America region is projected to hold the second-largest share during the forecast period. An aging population is more susceptible to orthopedic conditions, such as osteoarthritis and ligament injuries. Bioresorbable collagen implants are increasingly used in orthopedic surgeries for tissue repair and regeneration, aligning with the needs of this demographic. North America has a rapidly aging population, with over 16% of its citizens aged 65 and older. North American hospitals and healthcare facilities are early adopters of innovative medical technologies, including bioresorbable collagen implants. Ongoing technological advancements in these implants enhance patient outcomes and drive market growth. The United States alone spends over 17% of its GDP on healthcare, promoting investments in advanced medical technologies.

Bioresorbable Collagen Implant Market share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Bioresorbable Collagen Implant Market Players:

    • Allergan, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Zimmer Biomet Holdings, Inc.
    • Galderma S.A.
    • CollPlant Holdings Ltd.
    • Collagen Matrix, Inc.
    • Merz Pharma GmbH & Co. KGaA
    • RegenLab SA
    • Croma-Pharma GmbH
    • Dr. Suwelack AG & Co. KG
    • Mentor Worldwide LLC

Recent Developments

  • Zimmer Biomet acquired Embody, Inc., a privately-held medical device company focused on soft tissue healing, for USD 155 million at closing and up to an additional USD 120 million subject to achieving future regulatory and commercial milestones over three years. The acquisition was aimed at expanding Zimmer Biomet's portfolio of soft tissue healing products and solutions.
  • Zimmer Biomet merged with Biomet, Inc., to form a global leader in musculoskeletal healthcare. The merger combined Zimmer's and Biomet's portfolios of products and solutions, including joint reconstruction, sports medicine, and spine care.
  • Report ID: 5317
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of bioresorbable collagen implant is assessed at USD 1.48 billion.

The global bioresorbable collagen implant market size surpassed USD 1.38 billion in 2025 and is projected to witness a CAGR of over 8.2%, crossing USD 3.03 billion revenue by 2035.

By 2035, Asia Pacific is anticipated to capture a 37% revenue share in the bioresorbable collagen implant market, underpinned by the region’s expanding volume of orthopedic procedures and preference for minimally invasive techniques.

Key players in the market include Allergan, Inc., Zimmer Biomet Holdings, Inc., Galderma S.A., CollPlant Holdings Ltd., Collagen Matrix, Inc., Merz Pharma GmbH & Co. KGaA.

Bioresorbable Collagen Implant Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Buy Now Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos